News
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
GLP-1RA use necessitated shifting priorities in nutrition and lifestyle modification among patients with obesity, according ...
Ascletis Pharma has dosed the first obese or overweight subjects in the 13-week, multi-centre US Phase IIa trial of ASC30.
MASLD, a liver disease linked to obesity and poor lifestyle, is rising among children. Often symptomless early on, it can ...
A recent study conducted by researchers from the South African Medical Research Council (SAMRC) and Inkosi Albert Luthuli ...
The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant ...
As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...
Excessive physical exercise, especially without adequate rest, can damage the human body in various ways. In severe cases, it ...
Pharma giants are sweating on the results of a federal government request for guidance on adding weight loss drugs to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results